相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combinatorial Approaches to the Prevention and Treatment of HIV-1 Infection
Vanessa Pirrone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
A novel hybrid peptide targeting EGFR-expressing cancers
Masayuki Kohno et al.
EUROPEAN JOURNAL OF CANCER (2011)
Dual inhibition: a novel promising pharmacological approach for different disease conditions
Sazal Patyar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2011)
Quinpramine Ameliorates Rat Experimental Autoimmune Neuritis and Redistributes MHC Class II Molecules
Gerd Meyer Zu Hoerste et al.
PLOS ONE (2011)
An Aptamer-siRNA Chimera Suppresses HIV-1 Viral Loads and Protects from Helper CD4+ T Cell Decline in Humanized Mice
Charles Preston Neff et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Combining Independent Drug Classes into Superior, Synergistically Acting Hybrid Molecules
Andreas Mueller-Schiffmann et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Botulinum Neurotoxin: A Marvel of Protein Design
Mauricio Montal
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79 (2010)
CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity
Cheng-Jung Lai et al.
CANCER RESEARCH (2010)
Two-Headed PROTAC: An Effective New Tool for Targeted Protein Degradation
Kedra Cyrus et al.
CHEMBIOCHEM (2010)
Targeting the Undruggable Proteome: The Small Molecules of My Dreams
Craig M. Crews
CHEMISTRY & BIOLOGY (2010)
The Development of New Therapeutics for Alzheimer's Disease
M. D. Carter et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Novel Rational Drug Design Strategies with Potential to Revolutionize Malaria Chemotherapy
F. W. Muregi et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 Inhibitor for the Treatment of Cancer
Xiong Cai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Hybrid Inhibitors of Phosphatidylinositol 3-Kinase (PI3K) and the Mammalian Target of Rapamycin (mTOR): Design, Synthesis, and Superior Antitumor Activity of Novel Wortmannin-Rapamycin Conjugates
Semiramis Ayral-Kaloustian et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Protein Knockdown Using Methyl Bestatin-Ligand Hybrid Molecules: Design and Synthesis of Inducers of Ubiquitination-Mediated Degradation of Cellular Retinoic Acid-Binding Proteins
Yukihiro Itoh et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Recent Progress in the Development of Synthetic Hybrids of Natural or Unnatural Bioactive Compounds for Medicinal Chemistry
Svetlana B. Tsogoeva
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2010)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis et al.
NATURE (2010)
Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein
Peter O. Bauer et al.
NATURE BIOTECHNOLOGY (2010)
Impact of Nanotechnology on Drug Delivery
Omid C. Farokhzad et al.
ACS NANO (2009)
Modular nanotransporters of anticancer drugs conferring cell specificity and higher efficiency
A. S. Sobolev
BIOCHEMISTRY-MOSCOW (2009)
Preclinical and clinical studies of anticancer agent-incorporating polymer micelles
Yasuhiro Matsumura et al.
CANCER SCIENCE (2009)
Molecular Assembly of an Aptamer-Drug Conjugate for Targeted Drug Delivery to Tumor Cells
Yu-Fen Huang et al.
CHEMBIOCHEM (2009)
MTDL Design Strategy in the Context of Alzheimer's Disease: From Lipocrine to Memoquin and Beyond
M. L. Bolognesi et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Quinpramine is a novel compound effective in ameliorating brain autoimmune disease
Mahendra P. Singh et al.
EXPERIMENTAL NEUROLOGY (2009)
Targeting the mTOR Signaling Network for Cancer Therapy
Funda Meric-Bernstam et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells
Brenda F. Canine et al.
JOURNAL OF CONTROLLED RELEASE (2009)
The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
Mark E. Davis
MOLECULAR PHARMACEUTICS (2009)
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
Justin P. Dassie et al.
NATURE BIOTECHNOLOGY (2009)
Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells
Jiehua Zhou et al.
NUCLEIC ACIDS RESEARCH (2009)
Aptamers and aptamer targeted delivery
Amy C. Yan et al.
RNA BIOLOGY (2009)
Nanobiosystems
Mary-Margaret Seale-Goldsmith et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2009)
Hybrid molecules with a dual mode of action: Dream or reality?
Bernard Meunier
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Recent trends in targeted anticancer prodrug and conjugate design
Yashveer Singh et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Multi-target-directed ligands to combat neurodegenerative diseases
Andrea Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Development of an aryl hydrocarbon receptor antagonist using the proteolysis-targeting chimeric molecules approach: A potential tool for chemoprevention
Dinesh Puppala et al.
MOLECULAR PHARMACOLOGY (2008)
Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy
Jiehua Zhou et al.
MOLECULAR THERAPY (2008)
Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer
A. Rodriguez-Gonzalez et al.
ONCOGENE (2008)
Selection of a trioxaquine as an antimalarial drug candidate
Frederic Cosledan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Crystal structure of DNA-bound Co(III)-bleomycin B2:: Insights on intercalation and minor groove binding
Kristie D. Goodwin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Targeted degradation of the aryl hydrocarbon receptor by the PROTAC approach: A useful chemical genetic tool
Hyosung Lee et al.
CHEMBIOCHEM (2007)
Trioxaquines and heme-artemisinin adducts inhibit the in vitro formation of hemozoin better than chloroquine
Christophe Loup et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
A chimeric ligand approach leading to potent antiprion active acridine derivatives:: Design, synthesis, and biological investigations
Silke Dollinger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Targeting cancer cells by novel engineered modular transporters
Dinara G. Gilyazova et al.
CANCER RESEARCH (2006)
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras
James O. McNamara et al.
NATURE BIOTECHNOLOGY (2006)
Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments
Ralf Klingenstein et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Aptamer:toxin conjugates that specifically target prostate tumor cells
Ted C. Chu et al.
CANCER RESEARCH (2006)
Aptamer mediated siRNA delivery
Ted C. Chu et al.
NUCLEIC ACIDS RESEARCH (2006)
A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease?
PT Francis et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Prevention of Alzheimer's disease-associated Aβ aggregation by rationally designed nonpeptidic β-sheet ligands
P Rzepecki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mirror-image phage display: Aiming at the mirror
K Wiesehan et al.
CHEMBIOCHEM (2003)
Development of protacs to target cancer-promoting proteins for ubiquitination and degradation
KM Sakamoto et al.
MOLECULAR & CELLULAR PROTEOMICS (2003)
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
KM Sakamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
